Slate Medicines | RoundOS

Weekly digest by email

Loading companies…

Slate Medicines | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Feb 24, 2026	Series A	$130M	Forbion — Role not disclosedForesite Capital — Role not disclosedRA Capital Management — Role not disclosed

Investors

ForbionSeries A Foresite CapitalSeries A RA Capital ManagementSeries A

Coverage

Feb 24, 2026Slate Medicines · Series A

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26M · Series A

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

Sources

slatemedicines.com ↗